New Zealand Coastal Seafoods (ASX:NZS) has signed an MOU with Beyond Capital Limited Partnership (BCLP) to licence its two provisional patents.

The patents relate to the use of New Zealand green lipped mussels with fucoidan (bioactive seaweed compounds) for use as an anti-inflammatory treatment.

NZS says BCLP is focussed on opportunities across marine scientific research and natural nutrition, and will also help its business grow through connections to Asia.

The company?s share price closed up 33% today.